Transaction · 0001790340-25-000009

BERMAN ANN E

BERMAN ANN E, DIR, reported a transaction classified as grant at Immuneering Corp involving 17614.000000 shares for an estimated $0.00. Reported holdings after the transaction were 17614.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ADIR
IMRXImmuneering Corp
Filing timeJan 02
Trade dateJan 01, 2025
Filing · SECView on SEC
InsiderProfile
% of reported position tradedUnavailableNot calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

IMRX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
IMRX since 2025-01-02Filed 633 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001790340-25-000009
Stock Option
Transaction date
Jan 01, 2025
Filed Jan 02, 2025, 09:19 PM · 1d delay
Shares
17.6k sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
17.6k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Increase
-6score
Filing-only score

-6

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Pursuant to the Immuneering Corporation Non-Employee Director Compensation Program (the "Compensation Program"), the reporting person elected to receive this stock option in lieu of receiving the cash…

  2. F2

    The option vests and becomes exercisable as to 25% of the shares subject to the option upon the reporting person completing three months of continuous service as a Non-Employee Director (as defined in…

  3. F3

    Pursuant to the Compensation Program, the reporting person elected to receive this stock option in lieu of receiving the cash COB Retainer (as defined in the Compensation Program).

  4. F4

    The option vests and becomes exercisable as to 25% of the shares subject to the option upon the reporting person completing three months of continuous service as a Non-Employee Director (as defined in…

Original filing · 0001790340-25-000009
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

IMRX